EyePoint (EYPT) Net Equity Issued and Repurchased (2011 - 2025)

EyePoint (EYPT) reported Net Equity Issued and Repurchased of $166.8 million for Q4 2025, up 10.08% on a YoY basis from $151.5 million in Q4 2024, and up 2317.2% sequentially from $6.9 million in Q3 2025.

EyePoint (EYPT) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends

EyePoint (EYPT) has 13 years of Net Equity Issued and Repurchased data on file, last reported at $166.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Equity Issued and Repurchased rose 10.08% year-over-year to $166.8 million; the trailing twelve-month figure through Dec 2025 stood at $337.4 million (down 14.3% YoY), and the FY2025 full-year result was $173.4 million, up 6.2% from the prior year.
  • Net Equity Issued and Repurchased grew to $166.8 million in Q4 2025, from $6.9 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $230.0 million in Q4 2023 to a low of -$7.3 million in Q3 2021.
  • A 4-year average of $84.5 million and a median of $63.9 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • Peak annual rise in Net Equity Issued and Repurchased reached 470.21% in 2021, while the deepest fall reached 252.06% in 2021.
  • Tracing EYPT's Net Equity Issued and Repurchased over 4 years: stood at -$7.3 million in 2021, then jumped by 3243.36% to $230.0 million in 2023, then slumped by 34.12% to $151.5 million in 2024, then rose by 10.08% to $166.8 million in 2025.
  • Business Quant data shows EYPT's Net Equity Issued and Repurchased at $166.8 million in Q4 2025, $6.9 million in Q3 2025, and $151.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 166.79 Mn
Dec 31, 2025 166.79 Mn
Sep 30, 2025 6.90 Mn
Sep 30, 2025 6.90 Mn
Dec 31, 2024 151.52 Mn
Dec 31, 2024 151.52 Mn
Sep 30, 2024 12.20 Mn
Sep 30, 2024 12.20 Mn
Dec 31, 2023 230.00 Mn
Dec 31, 2023 230.00 Mn
Sep 30, 2021 -7.32 Mn
Sep 30, 2021 -7.32 Mn
Jun 30, 2021 -1,000.00
Jun 30, 2021 -1,000.00
Mar 31, 2021 115.67 Mn
Mar 31, 2021 115.67 Mn
Dec 31, 2020 25.12 Mn
Dec 31, 2020 25.12 Mn
Sep 30, 2020 4.81 Mn
Sep 30, 2020 4.81 Mn